Shiqing Xu

1.5k total citations
44 papers, 1.1k citations indexed

About

Shiqing Xu is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Shiqing Xu has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 13 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Molecular Biology. Recurrent topics in Shiqing Xu's work include Pancreatic function and diabetes (12 papers), Advanced Glycation End Products research (9 papers) and Diabetes and associated disorders (7 papers). Shiqing Xu is often cited by papers focused on Pancreatic function and diabetes (12 papers), Advanced Glycation End Products research (9 papers) and Diabetes and associated disorders (7 papers). Shiqing Xu collaborates with scholars based in China, United States and United Kingdom. Shiqing Xu's co-authors include Jinning Lou, Honglin Liu, Chen Wang, Liya Ye, Liang Peng, Hua Cai, Wenjian Zhang, Joe G. N. Garcia, Kai Huang and Lian‐Qiu Wu and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Nanoscale.

In The Last Decade

Shiqing Xu

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiqing Xu China 17 350 231 223 150 140 44 1.1k
Mark Warnock United States 16 323 0.9× 152 0.7× 143 0.6× 182 1.2× 72 0.5× 33 1.4k
Xiaoling Cao China 17 266 0.8× 306 1.3× 121 0.5× 177 1.2× 93 0.7× 39 904
Chiara Caselli Italy 22 296 0.8× 80 0.3× 369 1.7× 246 1.6× 115 0.8× 107 1.5k
Huaping Li China 25 638 1.8× 72 0.3× 176 0.8× 197 1.3× 100 0.7× 57 1.6k
Francesca Fortini Italy 19 240 0.7× 168 0.7× 89 0.4× 81 0.5× 55 0.4× 37 877
Wolfgang Hübl Austria 21 470 1.3× 62 0.3× 316 1.4× 189 1.3× 59 0.4× 68 1.7k
Isabella Zanella Italy 18 297 0.8× 201 0.9× 286 1.3× 277 1.8× 19 0.1× 54 1.4k
Guanghua Li China 19 344 1.0× 57 0.2× 245 1.1× 149 1.0× 102 0.7× 69 1.4k

Countries citing papers authored by Shiqing Xu

Since Specialization
Citations

This map shows the geographic impact of Shiqing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiqing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiqing Xu more than expected).

Fields of papers citing papers by Shiqing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiqing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiqing Xu. The network helps show where Shiqing Xu may publish in the future.

Co-authorship network of co-authors of Shiqing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shiqing Xu. A scholar is included among the top collaborators of Shiqing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiqing Xu. Shiqing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Lianhua, Jixiang Liu, Shiqing Xu, et al.. (2023). Inhibition of heterogeneous nuclear ribonucleoproteins A1 and oxidative stress reduces glycolysis via pyruvate kinase M2 in chronic thromboembolic pulmonary hypertension. Journal of Translational Internal Medicine. 12(4). 437–451. 3 indexed citations
2.
Wan, Jiafeng, Shiqing Xu, Jing Li, et al.. (2022). Facile synthesis of multifunctional pharmaceutical carbon dots for targeted bioimaging and chemotherapy of tumors. Nanoscale. 14(31). 11359–11368. 21 indexed citations
3.
Zhang, Heng, Hao Liu, Shiqing Xu, et al.. (2021). Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease. Pharmacological Research. 174. 105964–105964. 38 indexed citations
4.
Liu, Honglin, Hongting Tang, Hanlin Yang, et al.. (2020). Oct4 Regulates the Transition of Cancer Stem-Like Cells to Tumor Endothelial-Like Cells in Human Liver Cancer. Frontiers in Cell and Developmental Biology. 8. 563316–563316. 21 indexed citations
5.
You, Pengtao, et al.. (2020). Yu Gan Long Ameliorates Hepatic Fibrosis by Inhibiting PI3K/AKT, Ras/ERK and JAK1/STAT3 Signaling Pathways in CCl4-induced Liver Fibrosis Rats. Current Medical Science. 40(3). 539–547. 12 indexed citations
6.
7.
Xu, Shiqing, Jing Li, Min Zhai, et al.. (2019). 1,25-(OH)2D3 protects Schwann cells against advanced glycation end products-induced apoptosis through PKA-NF-κB pathway. Life Sciences. 225. 107–116. 15 indexed citations
8.
Li, Jing, Shiqing Xu, Kai Zhang, et al.. (2018). Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model. Stem Cell Research & Therapy. 9(1). 27–27. 23 indexed citations
9.
Jiang, Yongwei, Wenjian Zhang, Shiqing Xu, et al.. (2017). Transplantation of human fetal pancreatic progenitor cells ameliorates renal injury in streptozotocin-induced diabetic nephropathy. Journal of Translational Medicine. 15(1). 147–147. 10 indexed citations
10.
Wang, Meng, Wenjian Zhang, Shiqing Xu, et al.. (2017). TRB3 mediates advanced glycation end product-induced apoptosis of pancreatic β-cells through the protein kinase C β pathway. International Journal of Molecular Medicine. 40(1). 130–136. 10 indexed citations
11.
Xu, Shiqing, Yongwei Jiang, Hui Wang, et al.. (2015). C-peptide ameliorates renal injury in type 2 diabetic rats through protein kinase A-mediated inhibition of fibronectin synthesis. Biochemical and Biophysical Research Communications. 458(3). 674–680. 12 indexed citations
12.
Zhang, Wenjian, et al.. (2014). [The role of AGE and RAGE in diabetic neuropathy].. PubMed. 45(2). 137–9. 1 indexed citations
13.
Xu, Shiqing, et al.. (2013). Gliquidone decreases urinary protein by promoting tubular reabsorption in diabetic Goto-Kakizaki rats. Journal of Endocrinology. 220(2). 129–141. 10 indexed citations
14.
Wang, Hui, Wenjian Zhang, Cai H, et al.. (2011). α-cell loss from islet impairs its insulin secretion in vitro and in vivo. Islets. 3(2). 58–65. 3 indexed citations
15.
Zhang, Na, Wenjian Zhang, Cai H, et al.. (2010). Platelet adhesion and fusion to endothelial cell facilitate the metastasis of tumor cell in hypoxia-reoxygenation condition. Clinical & Experimental Metastasis. 28(1). 1–12. 28 indexed citations
16.
H, Cai, Shiqing Xu, Xiuli Men, et al.. (2009). [Isolation, purification, and functional evaluation of human pancreatic islet].. PubMed. 89(12). 836–40. 4 indexed citations
17.
Qian, Bo, Haiyan Wang, Xiuli Men, et al.. (2008). TRIB3 is implicated in glucotoxicity- and oestrogen receptor-stress-induced β-cell apoptosis. Journal of Endocrinology. 199(3). 407–416. 47 indexed citations
18.
Yang, Hong, Wenjian Zhang, Lian‐Qiu Wu, et al.. (2005). [Protection of liver sinusoidal endothelial cells from hypoxia-reoxygenation induced apoptosis by alpha-1 antitrypsin in vitro].. PubMed. 85(2). 106–10. 10 indexed citations
19.
Zhang, Yuanchun, Jing Li, Yuliang Zhan, et al.. (2004). Analysis of Serum Cytokines in Patients with Severe Acute Respiratory Syndrome. Infection and Immunity. 72(8). 4410–4415. 276 indexed citations
20.
Han, Yifei, et al.. (2001). The construction and function of Glycoprotein. 18(2). 1–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Warnock Breakdown of academic impact, for papers by Xiaoling Cao Breakdown of academic impact, for papers by Chiara Caselli Breakdown of academic impact, for papers by Huaping Li Breakdown of academic impact, for papers by Francesca Fortini Breakdown of academic impact, for papers by Wolfgang Hübl Breakdown of academic impact, for papers by Isabella Zanella Breakdown of academic impact, for papers by Guanghua Li
Rankless by CCL
2026